Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15822 articles
IL-15 super-agonist (ALT-803) enhances natural killer (NK) cell function against ovarian cancer.
Only animals treated with intraperitoneal ALT-803 displayed an NK dependent significant decrease in tumor.
»
12/15/16
IL-33 promotes colon cancer cell stemness via JNK activation and macrophage recruitment.
IL-33 dually targets tumor cells and macrophages.
»
02/22/17
Age-related reduction of antibody response against the human endogenous retrovirus K envelope in women.
IgG1 appeared to be the predominant subtype in the reduction of the IgG response by age.
»
11/16/15
PAK5 mediates cell:cell adhesion integrity via interaction with E-cadherin in bladder cancer cells.
Role for PAK5 in maintaining junctional stability.
»
02/21/17
NR1D1 recruitment to sites of DNA damage inhibits repair and is associated with chemosensitivity of breast cancer.
NR1D1 and its ligands provide therapeutic options that could enhance the outcomes of chemotherapy.
»
02/16/17
Epigenetic activation of WHSC1 functions as an oncogene and is associated with poor prognosis in cervical cancer.
WHSC1 is hypomethylated in cervical cancer.
»
09/25/16
The Association of Diabetes and Obesity With Prostate Cancer Progression: HCaP-NC.
Obesity was positively associated with CaP progression among Whites.
»
08/31/16
USP39 promotes colorectal cancer growth and metastasis through the Wnt/β-catenin pathway.
Expression of four crucial proteins of Wnt/β-catenin pathway reduced as a result of USP39 knockdown.
»
09/04/16
Predictive value of circulating tumor cells (CTCs) captured by microfluidic device in patients with epithelial ovarian cancer.
Isolated CTCs (successfully cultured ex vivo in two patients) showed greater sensitivity to anticancer drugs.
»
01/30/17
Peptide-pulsed dendritic cell vaccine in combination with carboplatin and paclitaxel chemotherapy for stage IV melanoma.
DCCP may be beneficial for HLA-A24 melanoma patients with a WT1-IR.
»
03/07/17
< Prev
Next >